48,830
edits
m (→General) |
|||
Line 113: | Line 113: | ||
*Common. | *Common. | ||
*Usu. secondary to BCG treatment of bladder cancer. | *Usu. secondary to BCG treatment of bladder cancer. | ||
*Several | *Several classifications exist<ref name=pmid17092284>{{Cite journal | last1 = Uzoh | first1 = CC. | last2 = Uff | first2 = JS. | last3 = Okeke | first3 = AA. | title = Granulomatous prostatitis. | journal = BJU Int | volume = 99 | issue = 3 | pages = 510-2 | month = Mar | year = 2007 | doi = 10.1111/j.1464-410X.2006.06585.x | PMID = 17092284 | URL = http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2006.06585.x/full }}</ref> - the most commonly used is by ''Epstein & Hutchins''. | ||
=====Epstein & Hutchins classification===== | =====Epstein & Hutchins classification===== |
edits